Kestra Advisory Services, LLC Seres Therapeutics, Inc. Call Options Transaction History
Kestra Advisory Services, LLC
- $19.6 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding MCRB
# of Institutions
38Shares Held
29MCall Options Held
103KPut Options Held
53K-
Black Rock Inc. New York, NY1.76MShares$27.2 Million0.0% of portfolio
-
Morgan Stanley New York, NY150KShares$2.31 Million0.0% of portfolio
-
Miller Financial Services LLC Marshall, MI15KShares$231,6000.02% of portfolio
-
Pictet Asset Management Sa Geneva 73, V813.7KShares$211,4040.0% of portfolio
-
Jpmorgan Chase & CO New York, NY1.3KShares$20,1330.0% of portfolio
About Seres Therapeutics, Inc.
- Ticker MCRB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 124,072,000
- Market Cap $1.92B
- Description
- Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...